CPT code 33901 covers bilateral endovascular stent placement in the pulmonary arteries performed via native vascular access. This interventional cardiac procedure addresses pulmonary artery stenosis by restoring vessel diameter and improving pulmonary blood flow. As a high-acuity, device-based intervention typically performed in hospital catheterization labs or interventional radiology suites, the code is relevant for cardiovascular surgery, congenital heart disease programs, and advanced pulmonary vascular care nationally.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, common billing considerations, and the types of benchmarks and policy topics that typically affect utilization and coverage decisions for high-cost device procedures. The publication highlights service setting expectations, bilateral designation implications for coding, and where readers can expect to find payer-specific coverage language and reimbursement policy updates.

The report provides practical reference material for coding teams, revenue cycle professionals, and clinical program leaders: expected service line classification, documentation touchpoints that support medical necessity, and an outline of typical payer coverage pathways. Data not available in the input will be clearly noted in specific sections; this executive summary focuses on the national clinical and billing relevance of CPT code 33901 and what readers should learn about its operational and policy context.